DRUGS MADE IN AMERICA ACQUISITION II CORP.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $175.0K | $347.7K | $223 | $315.1K | $4.4K | $7.0K | $17.0K | $120.1K |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $217.8K | $351.8K | $26.0K | $896.4K | — | — | $59.6K | — |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $514.1M | $509.7M | $505.0M | $501.0M | — | — | $138.1K | — |
| Liabilities | ||||||||
| Accounts Payable | $12.3K | $49.2K | $99.4K | $4.6K | — | — | — | — |
| Total Current Liabilities | $644.6K | $666.3K | $300.9K | $677.3K | — | — | $254.8K | — |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $18.1M | $18.2M | $17.8M | $18.2M | — | — | $254.8K | — |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-17.9M | $-17.8M | $-17.8M | $-17.3M | — | — | $-151.7K | — |
| Total Stockholders' Equity | $-17.9M | $-17.8M | $-17.8M | $-17.3M | $-214.1K | $-176.0K | $-116.7K | $-6.7K |